Over 45 cancer-associated BRAF mutations have been identified [7] with a high frequency in specific cancers, including 40–60% of melanoma [6], 30–50% of papillary thyroid, 5–20% of colorectal, and ∼30% of ovarian cancer [7]. Here, BRAF is linked to cancer.